Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EBITDA: 2009-2025

Historic EBITDA for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $33.7 million.

  • BIO-TECHNE's EBITDA fell 35.04% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.7 million, marking a year-over-year decrease of 56.31%. This contributed to the annual value of $91.8 million for FY2025, which is 41.08% down from last year.
  • BIO-TECHNE's EBITDA amounted to $33.7 million in Q3 2025, which was up 649.22% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's EBITDA registered a high of $84.9 million during Q4 2021, and its lowest value of $4.5 million during Q2 2025.
  • In the last 3 years, BIO-TECHNE's EBITDA had a median value of $37.6 million in 2024 and averaged $39.6 million.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 306.08% in 2021, then crashed by 88.04% in 2025.
  • Over the past 5 years, BIO-TECHNE's EBITDA (Quarterly) stood at $84.9 million in 2021, then decreased by 21.46% to $66.7 million in 2022, then slumped by 37.29% to $41.8 million in 2023, then crashed by 77.70% to $9.3 million in 2024, then tumbled by 35.04% to $33.7 million in 2025.
  • Its EBITDA stands at $33.7 million for Q3 2025, versus $4.5 million for Q2 2025 and $26.2 million for Q1 2025.